ArticleJACC. Case reports2026
Simultaneous TAVR and EVAR for Severe Aortic Regurgitation With Giant Abdominal Aortic Aneurysm.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe present an older male with severe aortic regurgitation scheduled for transcatheter aortic valve replacement (TAVR). Preoperative imaging identified a giant eccentric abdominal aortic aneurysm at high risk of rupture. This risk was mitigated by a single-stage combined procedure of TAVR and endovascular aneurysm repair. KEY STEPS: Two 8-F sheaths were respectively inserted into the bilateral femoral arteries. We then sequentially dilated the right femoral artery access using 14-F, 18-F, and 20-F introducer sheaths. The self-expanding stent system Endurant II was inserted and released. Coronary angiography assessed the degree of coronary artery stenosis. A 20-F sheath was inserted into the right femoral artery, and then we deployed the Evolut Pro + prosthetic valve. POTENTIAL PITFALLS: Potential pitfalls include the following: paravalvular leakage, valve displacement or detachment, and rupture of aneurysms. TAKE-HOME MESSAGE: For surgical high-risk patients with concurrent abdominal aortic aneurysm and severe aortic valve disease, the simultaneous implementation of TAVR and endovascular aneurysm repair may represent a viable therapeutic option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.